When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BPMC - FDA OKs Blueprint's pralsetinib for certain type of lung cancer
Blueprint Medicines Corporation
Under accelerated review status, the FDA approves Blueprint Medicine's (NASDAQ:BPMC) Gavreto (pralsetinib) for the treatment of adults with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC).
More news on: Blueprint Medicines Corporation, Healthcare stocks news,